药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Econazole
Teprotumumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Teprotumumab.
Econazole
XmAb 2513
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with XmAb 2513.
Econazole
Carotuximab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Carotuximab.
Econazole
Elotuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Elotuzumab.
Econazole
Motavizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Motavizumab.
Econazole
Sonepcizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Sonepcizumab.
Econazole
BIIB015
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with BIIB015.
Econazole
Clenoliximab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Clenoliximab.
Econazole
Nimotuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Nimotuzumab.
Econazole
Ipilimumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Ipilimumab.
Econazole
Lumiliximab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Lumiliximab.
Econazole
Eldelumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Eldelumab.
Econazole
IMC-1C11
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with IMC-1C11.
Econazole
Caplacizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Caplacizumab.
Econazole
TB-402
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with TB-402.
Econazole
IPH 2101
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with IPH 2101.
Econazole
Olaratumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Olaratumab.
Econazole
Glembatumumab vedotin
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Glembatumumab vedotin.
Econazole
Leronlimab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Leronlimab.
Econazole
CT-011
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with CT-011.